Research
Hormonal
Hypothalamic inflammation and endoplasmic reticulum stress are key drivers of leptin resistance, mediated by inflammatory cytokines like IL-6 and TNF-alpha induced by high-fat diets.
High-fat diets trigger inflammation in fat and liver tissue, which releases cytokines (IL-6, TNF-alpha) that disrupt leptin signaling in the brain. Managing inflammation through diet quality (reducing high-fat intake) may help restore leptin sensitivity.
GoodSupportsHIGH confidence
Mattace Raso et al demonstrated that a high-fat diet induces low-grade inflammation in peripheral tissues (especially in adipose tissue and the liver), leading to an increase in inflammatory cytokines, such as IL-6 and tumor necrosis factor (TNF)-α... Additionally, hypothalamic inflammation, endoplasmic reticulum stress, and autophagy disorders are involved in the development of obesity-associated leptin resistance.
Why this rating
Supported by multiple citations regarding cytokine effects and high-fat diet models.
Source
<p>Leptin resistance: underlying mechanisms and diagnosis</p>
О. В. Груздева et al. · Diabetes Metabolic Syndrome and Obesity · 2019
DOI 10.2147/dmso.s182406
narrative_reviewCited 280×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Leptin resistance in obesity is primarily driven by impaired transport of leptin across the blood-brain barrier and intracellular signaling defects (specifically JAK2-STAT3 pathway inhibition by SOCS3 and PTP1B), rather than leptin deficiency.Good
- High serum leptin levels (>25-30 ng/mL) saturate the blood-brain barrier transport system, preventing leptin from entering the brain and thereby contributing to leptin resistance.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →